Glenmark Pharmaceuticals’ arm gets tentative approval for Regadenoson Injection
glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by United States Food & Drug Administration (USFDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas … Read more